Your session is about to expire
← Back to Search
Dexrazoxane for Soft Tissue Sarcoma
Study Summary
This trial is looking at whether giving dexrazoxane with standard of care doxorubicin affects the progression of the disease.
- Soft Tissue Sarcoma
- Hemangiosarcoma
- Fibrosarcoma
- Pleomorphic Sarcoma
- Leiomyosarcoma
- Myxofibrosarcoma
- Peripheral Nerve Sheath Tumor
- Epithelioid Sarcoma
- Liposarcoma
- Synovial Sarcoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 73 Patients • NCT02584309Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many patients are part of this experiment?
"As of now, this clinical trial does not have any open positions. However, this may change in the future as the study was last updated on 4/19/2022. There are currently 521 other trials for fibrosarcoma and 386 studies involving Dexrazoxane that are actively recruiting patients if you are interested."
Could you please share any other scientific research that has been conducted with Dexrazoxane?
"As of now, there are 386 ongoing studies observing the effects of Dexrazoxane. Out of these, 121 are in Phase 3. Additionally, while a few investigations are taking place in Providence, Rhode island, there are 23157 other sites running similar trials."
Has this type of clinical trial been conducted before?
"As of now, there are 386 ongoing clinical trials for Dexrazoxane in 67 different countries and 1935 cities. The very first trial happened in 1997 and was sponsored by Alfacell. That study had 300 participants and completed Phase 3 drug approval. In the 24 years since then, 680 more trials have taken place."
Has Dexrazoxane received approval from the Federal Drug Administration?
"Dexrazoxane is a Phase 2 drug, so while there is some safety data, we do not yet know if it is effective. Our team rates its safety as a 2."
If a patient wanted to enroll today, would they be able to?
"As of right now, this clinical trial is not looking for any more patients. It was first posted on February 22nd, 2016 and last updated on April 19th, 2022. If you are interested in other research opportunities, 521 trials for fibrosarcoma and 386 studies involving Dexrazoxane are currently admitting patients."
Share this study with friends
Copy Link
Messenger